Literature DB >> 9683950

Systemic risk factors for idiopathic macular holes: a case-control study.

J R Evans1, S D Schwartz, J D McHugh, Y Thamby-Rajah, S A Hodgson, R P Wormald, Z J Gregor.   

Abstract

PURPOSE/
BACKGROUND: The idiopathic full-thickness macular hole (IFTMH) is an important cause of poor vision in the elderly affecting predominantly women over the age of 60 years. While it is accepted that vitreoretinal traction is an important local factor in the development of IFTMH, the underlying cause is not known. The aim of this study was to identify possible systemic risk factors for the development of IFTMH.
METHODS: Two hundred and thirty-seven patients with IFTMH (cases) attending the Macular Hole Clinic at Moorfields Eye Hospital were identified. These were compared with 172 patients without macular holes (controls) attending other clinics in the same hospital. Cases and controls were frequency-matched by sex. The prevalence of the following factors in both groups was ascertained by interview: ethnic origin, place of birth, housing tenure, any systemic diseases, current and lifetime consumption of medication, severe dehydrational episodes, menstrual and obstetric history, onset and severity of menopause and use of exogenous oestrogens (in women only), osteoporosis, vegetarianism, use of vitamin supplementation, and smoking and alcohol consumption. Height and weight were measured for all participants.
RESULTS: Cases of IFTMH macular holes were predominantly women (67%) and aged 65 years and older (74%). We found very few systemic risk factors that were significantly associated with IFTMH. There was a higher prevalence of diabetes in controls (12% vs 5%). There was no association between the majority of indicators of oestrogen exposure in women and macular holes, but cases had a more difficult menopause as judged by the severity of hot flushes at menopause: odds ratio 2.6 (1.4-4.6).
CONCLUSIONS: In common with other studies, we found only a few systemic factors associated with IFTMH. The study did confirm, however, that IFTMH is a strongly gender-related disease. There is some evidence for the role of sudden changes in hormonal balance, as seen by the increased reporting of severity of symptoms around the menopause along with (statistically non-significant) increased risks associated with hysterectomy and oophorectomy. The particular aetiological factor which puts women at increased risk of macular holes requires further studies.

Entities:  

Mesh:

Year:  1998        PMID: 9683950     DOI: 10.1038/eye.1998.60

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Are biometric parameters a risk factor for idiopathic macular hole formation? Results of a matched case-control series.

Authors:  S P Shah; C Bunce; R L Johnston; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Bilateral macular hole in a patient with chronic renal failure after recurrent deep vein thrombosis.

Authors:  Zisis Gatzioufas; Matthias Krause; Ursula Löw; Berthold Seitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-15       Impact factor: 3.117

3.  Measurement of retinal thickness in macular region of high myopic eyes using spectral domain OCT.

Authors:  Ai-Ping Song; Xin-Yi Wu; Jian-Rong Wang; Wei Liu; Yan Sun; Tao Yu
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

4.  Tamoxifen therapy conveys increased risk of developing a macular hole.

Authors:  Brendan G Cronin; Christopher K Lekich; Robert D Bourke
Journal:  Int Ophthalmol       Date:  2006-09-15       Impact factor: 2.031

5.  Retinal thickness measured by spectral-domain optical coherence tomography in eyes without retinal abnormalities: the Beaver Dam Eye Study.

Authors:  Chelsea E Myers; Barbara E K Klein; Stacy M Meuer; Maria K Swift; Charles S Chandler; Yijun Huang; Sapna Gangaputra; Jeong W Pak; Ronald P Danis; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2014-11-25       Impact factor: 5.258

6.  Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.

Authors:  Alexandra Wexler; Trond Sand; Tor B Elsås
Journal:  BMC Ophthalmol       Date:  2010-05-13       Impact factor: 2.209

7.  Estrogen antagonist and development of macular hole.

Authors:  Song Ee Chung; Seong Wook Kim; Hye Won Chung; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2010-10-05

8.  Vitreo-retinal traction and anastrozole use.

Authors:  Alvin Eisner; Emily J Thielman; Julie Falardeau; John T Vetto
Journal:  Breast Cancer Res Treat       Date:  2008-08-20       Impact factor: 4.872

9.  Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.

Authors:  Bhanu Dasari; Jaya R P Prasanthi; Craig Meiers; Brij B Singh; Othman Ghribi
Journal:  Curr Eye Res       Date:  2013-07-10       Impact factor: 2.424

10.  Macular Abnormalities Associated With 5α-Reductase Inhibitor.

Authors:  Yong Kyun Shin; Geun Woo Lee; Se Woong Kang; Sang Jin Kim; A Young Kim
Journal:  JAMA Ophthalmol       Date:  2020-07-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.